Odyssey Health (ODYY) Notes Payables (2014 - 2026)

Odyssey Health has disclosed Notes Payables across 13 years of filings, most recently posting $2.5 million for Q2 2026.

• Quarterly Notes Payables rose 28.1% year-over-year to $2.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2.5 million (up 28.1% YoY) and the FY2025 annual result came in at $1.9 million, up 11.84% from the prior year.
• Notes Payables rose to $2.5 million in Q2 2026, from $2.2 million in the prior quarter.
• Across five years, Notes Payables topped out at $2.5 million in Q2 2026 and bottomed at $100000.0 in Q4 2025.
• The 5-year median for Notes Payables is $1.8 million (2023), against an average of $1.8 million.
• Year-over-year, Notes Payables jumped 291.14% in 2022 and plunged 94.6% in 2025.
• Odyssey Health's Notes Payables stood at $1.7 million in 2022, then surged by 30.45% to $2.3 million in 2023, then slipped by 17.66% to $1.9 million in 2024, then plunged by 94.6% to $100000.0 in 2025, then soared by 2442.32% to $2.5 million in 2026.
• According to Business Quant data, Notes Payables over the past three periods registered $2.5 million, $2.2 million, and $100000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.